VANCOUVER, BC – Bold Therapeutics, a clinical-stage metallotherapeutics company, has been invited to speak at the 2024 ‘Metals in Medicine’ GRC held in Andover, New Hampshire between June 23 to 28,… Read More
Selected fellows represent a diverse group of outstanding youth across Canada making a positive impact on people, society and the planet that will have the unique opportunity to attend the… Read More
PORTLAND, OR – Molecular You, a leading innovator in providing multi-biomarker testing and predictive health analytics, is pleased to announce the appointment of Dr. Murdoc Khaleghi as Chief Medical Officer… Read More
VANCOUVER, BC – Life Sciences BC (LSBC) is pleased to announce the recipients of the 26th Annual Life Sciences BC Awards presented by Farris. These awards recognize the exceptional achievements… Read More
Submission is supported by 48-week results from the Phase 3 GALAXI and GRAVITI programs TREMFYA® is the only IL-23 inhibitor to demonstrate strong endoscopic outcomes with subcutaneous (SC) induction, consistent… Read More
